Spyre Therapeutics | 8-K:重大事件
Spyre Therapeutics | 4:持股变动声明-高管 Burrows Scott L
Spyre Therapeutics | 4:持股变动声明-高管 King-Jones Heidy
Spyre Therapeutics | 4:持股变动声明-高管 Turtle Cameron
Spyre Therapeutics | 144:拟议出售证券
Spyre Therapeutics | 8-K:重大事件
Spyre Therapeutics | SCHEDULE 13G/A:其他
Spyre Therapeutics | SCHEDULE 13G/A:其他
Spyre Therapeutics | 4:持股变动声明-董事 Albers Jeffrey W.
Spyre Therapeutics | 144:拟议出售证券
Spyre Therapeutics | 144:拟议出售证券
Spyre Therapeutics | 4:持股变动声明-高管 Burrows Scott L
Spyre Therapeutics | 4:持股变动声明-高管 Turtle Cameron
Spyre Therapeutics | 8-K:Spyre Therapeutics公布2026年第二季度财务业绩并发布公司最新动态
Spyre Therapeutics | 10-Q:2026财年二季报
Spyre Therapeutics | 144:拟议出售证券
Spyre Therapeutics | 4:持股变动声明-高管 Burrows Scott L
Spyre Therapeutics | 4:持股变动声明-高管 Sloan Sheldon
Spyre Therapeutics | 4:持股变动声明-高管 Turtle Cameron
Spyre Therapeutics | 144:拟议出售证券